Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5‐ASA use

Klaus Herrlinger(Robert Bosch Hospital), Eduard F. Stange(John Radcliffe Hospital), J. Steinhoff(University of Lübeck), Klaus Fellermann(Apple (Israel)), Mirja K. Noftz(University of Lübeck), K. J. Schmidt(University Hospital Schleswig-Holstein)
Alimentary Pharmacology & Therapeutics
March 6, 2001
Cited by 82


Related Papers